| Product Code: ETC7319697 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Acute Coronary Syndrome Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Acute Coronary Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Acute Coronary Syndrome Market - Industry Life Cycle |
3.4 Ghana Acute Coronary Syndrome Market - Porter's Five Forces |
3.5 Ghana Acute Coronary Syndrome Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Ghana Acute Coronary Syndrome Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Ghana Acute Coronary Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lifestyle diseases such as obesity and diabetes leading to a higher incidence of acute coronary syndrome in Ghana. |
4.2.2 Improving healthcare infrastructure and access to cardiac care services in Ghana. |
4.2.3 Rising awareness about the importance of early detection and treatment of cardiovascular diseases in the country. |
4.3 Market Restraints |
4.3.1 Limited healthcare budget and resources allocated to cardiovascular diseases in Ghana. |
4.3.2 Lack of specialized healthcare professionals and facilities for the diagnosis and treatment of acute coronary syndrome. |
4.3.3 High cost of advanced cardiac treatments and medications in the Ghanaian market. |
5 Ghana Acute Coronary Syndrome Market Trends |
6 Ghana Acute Coronary Syndrome Market, By Types |
6.1 Ghana Acute Coronary Syndrome Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Ghana Acute Coronary Syndrome Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Ghana Acute Coronary Syndrome Market Revenues & Volume, By ST-elevation myocardial infarction (STEMI), 2021- 2031F |
6.1.4 Ghana Acute Coronary Syndrome Market Revenues & Volume, By Non-ST-elevation myocardial infarction (NSTEMI), 2021- 2031F |
6.1.5 Ghana Acute Coronary Syndrome Market Revenues & Volume, By Unstable angina (UA), 2021- 2031F |
6.2 Ghana Acute Coronary Syndrome Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Ghana Acute Coronary Syndrome Market Revenues & Volume, By Antithrombotic, 2021- 2031F |
6.2.3 Ghana Acute Coronary Syndrome Market Revenues & Volume, By Antihypertensive, 2021- 2031F |
6.2.4 Ghana Acute Coronary Syndrome Market Revenues & Volume, By Statin drugs, 2021- 2031F |
7 Ghana Acute Coronary Syndrome Market Import-Export Trade Statistics |
7.1 Ghana Acute Coronary Syndrome Market Export to Major Countries |
7.2 Ghana Acute Coronary Syndrome Market Imports from Major Countries |
8 Ghana Acute Coronary Syndrome Market Key Performance Indicators |
8.1 Average waiting time for patients to receive coronary intervention. |
8.2 Percentage increase in the number of cardiac catheterization procedures performed annually. |
8.3 Adoption rate of evidence-based guidelines for the management of acute coronary syndrome in healthcare facilities. |
9 Ghana Acute Coronary Syndrome Market - Opportunity Assessment |
9.1 Ghana Acute Coronary Syndrome Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Ghana Acute Coronary Syndrome Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Ghana Acute Coronary Syndrome Market - Competitive Landscape |
10.1 Ghana Acute Coronary Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Ghana Acute Coronary Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |